ERBB2 and breast cancer: The generated 16–19 MDTG;neu bitransgenic female mice still developed mammary tumors; however, compared to MMTV-neu mice, MDTG;neu bitransgenic mice from all three strains exhibited significantly delayed tumor formation (Fig. 5).